Knie Robb
SEC insider (Form 3/4/5 filer). CIK 0001609695. CEO and President at Hoth Therapeutics, Inc. (HOTH). 5 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in NEW YORK, NY.
Companies Knie Robb has filed insider reports for
- Hoth Therapeutics, Inc. (HOTH): Director, Officer, CEO and President
Knie Robb
CIK: 0001609695
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HOTH
Hoth Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 26, 2026RKTO
Rocket One Inc.
AwardDirectOptions
550K shares- - Aug 28, 2025HOTH
Hoth Therapeutics, Inc.
Tax PaymentDirect310.7K shares at avg. $1.21$376K - Aug 27, 2025HOTH
Hoth Therapeutics, Inc.
AwardDirect800K shares- - Jan 14, 2025HOTH
Hoth Therapeutics, Inc.
AwardDirectOptions
93K shares- - Jan 14, 2025HOTH
Hoth Therapeutics, Inc.
AwardDirectOptions
7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  RKTO Rocket One Inc. | Award Options | 550,000 | - | - | Direct |
| Aug 28, 2025 | HOTH Hoth Therapeutics, Inc. | Tax Payment | 310,744 | $1.21 | $376,000 | Direct |
| Aug 27, 2025 | HOTH Hoth Therapeutics, Inc. | Award | 800,000 | - | - | Direct |
| Jan 14, 2025 | HOTH Hoth Therapeutics, Inc. | Award Options | 93,000 | - | - | Direct |
| Jan 14, 2025 | HOTH Hoth Therapeutics, Inc. | Award Options | 7,000 | - | - | Direct |
1-5 of 5 transactions